Funny how the USA Phase III trial in 2011 nor the cuv9900 trial were not listed in the letter as key expected developments for 2011.
Are you going to tell me that if the FDA granted the green light for USA Phase III to begin as they hoped in 2011 or this cuv9900 that the bragged about last year didn't start in Q1 2011 they wouldn't have listed those as their key developments that materialized?
Ridiculous.
Funny how they were omitted.
Shareholders should have been updated on both of those. Period.
Funny how the USA Phase III trial in 2011 nor the cuv9900 trial...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.68 |
Change
-0.240(1.61%) |
Mkt cap ! $735.1M | |||
| Open | High | Low | Value | Volume |
| $14.75 | $14.92 | $14.65 | $503.5K | 34.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 448 | $14.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.74 | 149 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |